Related Experiment Video
Updated: Jul 25, 2025
10:42
Subculture and Cryopreservation of Esophageal Adenocarcinoma Organoids: Pros and Cons for Single Cell Digestion
Published on: July 6, 2022
3.8K
Organ and Function Preservation in Gastrointestinal Malignancies.
1Division of Radiation Oncology, Department of Oncology, McMaster University, Juravinski Cancer Centre, Hamilton, Ontario, Canada.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|June 25, 2023
Summary
Brachytherapy boost significantly improves organ preservation rates in gastrointestinal malignancies like esophageal and rectal cancers. This radiation technique allows for escalated doses, crucial for successful outcomes and avoiding surgery.
Area of Science:
- Oncology
- Radiation Oncology
- Gastrointestinal Surgery
Background:
- Radiation therapy is vital for organ preservation in gastrointestinal malignancies.
- A watch and wait strategy can avoid surgery for select patients.
- Brachytherapy boost enables escalated radiation doses, enhancing organ preservation success.
Purpose of the Study:
- To describe the role of brachytherapy in esophageal and rectal cancers.
- To outline indications, procedures, and dosage for brachytherapy in these malignancies.
- To advocate for brachytherapy integration into radiation oncology training.
Main Methods:
- Review of brachytherapy applications in esophageal and rectal cancer.
- Discussion of treatment indications, procedural techniques, and dose/fractionation regimens.
- Analysis of current barriers to brachytherapy use.
Main Results:
- Brachytherapy is a key component in achieving organ preservation.
- Evidence supports its role in both radical treatment and palliation.
- Current underutilization is not justified by published data.
Conclusions:
- Brachytherapy is essential for improving organ preservation in gastrointestinal cancers.
- Enhanced training and availability are needed to overcome current limitations.
- Increased adoption of brachytherapy is recommended for better patient outcomes.
